transplant rejection
Israeli Liquid Biopsy Startup Senseera Raises $7.1M in Seed Round
The funding will help the company commercialize a blood-based liver transplant rejection test as it continues to push for its platform in other disease research.
Thermo Fisher Scientific Deal Expands Possibilities for Exosome Dx Business, Bio-Techne CEO Says
Premium
The deal with Thermo Fisher is for the development of Bio-Techne's second test in its Exosome Diagnostics portfolio, a multigene assay for kidney transplant rejection.